Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis

被引:63
|
作者
Motl, Robert W. [1 ]
McAuley, Edward [1 ]
Sandroff, Brian M. [1 ]
机构
[1] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA
来源
PHYSICAL THERAPY | 2013年 / 93卷 / 08期
关键词
SELF-EFFICACY; SYMPTOMS; INDIVIDUALS; EXERCISE; ADHERENCE; ADULTS; SCALE; PAIN;
D O I
10.2522/ptj.20120479
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background. Physical activity is beneficial for people with multiple sclerosis (MS), but this population is largely inactive. There is minimal information on change in physical activity and its correlates for informing the development of behavioral interventions. Objective. This study examined change in physical activity and its symptomatic, social-cognitive, and ambulatory or disability correlates over a 2.5-year period of time in people with relapsing-remitting multiple sclerosis. Methods. On 6 occasions, each separated by 6 months, people (N=269) with relapsing-remitting multiple sclerosis completed assessments of symptoms, self-efficacy, walking impairment, disability, and physical activity. The participants wore an accelerometer for 7 days. The change in study variables over 6 time points was examined with unconditional latent growth curve modeling. The association among changes in study variables over time was examined using conditional latent growth curve modeling, and the associations were expressed as standardized path coefficients (beta). Results. There were significant linear changes in self-reported and objectively measured physical activity, self-efficacy, walking impairment, and disability over the 2.5-year period; there were no changes in fatigue, depression, and pain. The changes in self-reported and objective physical activity were associated with change in self-efficacy (beta=.49 and beta=.61, respectively), after controlling for other variables and confounders. Limitations. The primary limitations of the study were the generalizability of results among those with progressive multiple sclerosis and inclusion of a single variable from social-cognitive theory. Conclusions. Researchers should consider designing interventions that target self-efficacy for the promotion and maintenance of physical activity in this population.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [21] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [22] Subtypes of relapsing-remitting multiple sclerosis identified by network analysis
    Howlett-Prieto, Quentin
    Oommen, Chelsea
    Carrithers, Michael D.
    Wunsch II, Donald C.
    Hier, Daniel B.
    FRONTIERS IN DIGITAL HEALTH, 2023, 4
  • [23] Cognitive but Not Affective Theory of Mind Deficits in Mild Relapsing-Remitting Multiple Sclerosis
    Roca, Maria
    Manes, Facundo
    Gleichgerrcht, Ezequiel
    Ibanez, Agustin
    Gonzalez de Toledo, Maria E.
    Marenco, Victoria
    Bruno, Diana
    Torralva, Teresa
    Sinay, Vladimiro
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2014, 27 (01) : 25 - 30
  • [24] Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
    Gonzalez, Miguel Llaneza
    Rueda, Pedro Carrascal
    Sanchez, Olga Delgado
    Guerra, Monica Borges
    Antiguedad, Alfredo Rodriguez
    Baladron, Alberto Morell
    Rios, Noelia Becerril
    Rovira, Alex
    Lallana, Virgina Meca
    Benedito-Palos, Laura
    Comellas, Marta
    Vilanova, David
    Echeto, Ainara
    Perez, Xavier
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 84
  • [25] Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis
    Knowles, Lindsey M.
    Phillips, Kala M.
    Herring, Tracy E.
    Alschuler, Kevin N.
    Jensen, Mark P.
    Turner, Aaron P.
    Ehde, Dawn M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2021, 102 (10): : 1959 - 1964
  • [26] Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs
    Miller, Aaron E.
    Rhoades, Robert W.
    CURRENT OPINION IN NEUROLOGY, 2012, 25 : S4 - S10
  • [27] Are Sirtuins 1 and 2 Relevant Players in Relapsing-Remitting Multiple Sclerosis?
    Chojdak-Lukasiewicz, Justyna
    Bizon, Anna
    Koltuniuk, Aleksandra
    Waliszewska-Prosol, Marta
    Budrewicz, Slawomir
    Piwowar, Agnieszka
    Pokryszko-Dragan, Anna
    BIOMEDICINES, 2024, 12 (09)
  • [28] The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
    Madsen, Claus
    BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [29] Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis
    Chaseling, Georgia K.
    Allen, Dustin R.
    Vucic, Steve
    Barnett, Michael
    Frohman, Elliot
    Davi, Scott L.
    Jay, Ollie
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 29 : 62 - 67
  • [30] Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
    Ozel, Osman
    Vaughn, Caila B.
    Eckert, Svetlana P.
    Jakimovski, Dejan
    Lizarraga, Alexis A.
    Weinstock-Guttman, Bianca
    PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 373 - 384